Satoru Todo

Improving the Oral Bioavailability of Albendazole in Rabbits by the Solid Dispersion Technique

S. Todo, K. Iseki, K. Miyazaki, 1999, The Journal of pharmacy and pharmacology.

Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature

D Pinkel, S Todo, S. Ishii, 2008, Oncogene.

A phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients

H. Yamana, Yuji Sato, S. Todo, 2004, British Journal of Cancer.

Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma

Y. Arai, M. Ohira, A. Nakagawara, 2008, British Journal of Cancer.

An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis.

S. Todo, J. Nishihira, Y. Sato, 2000, Cytokine.

Development of a yeast stop codon assay readily and generally applicable to human genes.

M. Yano, M. Tada, K. Furuuchi, 2001, The American journal of pathology.

Long‐Term Hepatic Allograft Acceptance Based on CD40 Blockade by ASKP1240 in Nonhuman Primates

K. Yamashita, K. Wakayama, Tomomi Suzuki, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The Impact of c‐Fos/Activator Protein‐1 Inhibition on Allogeneic Pancreatic Islet Transplantation

S. Todo, S. Shibasaki, K. Yamashita, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas.

A. Nakagawara, S. Todo, S. Sakiyama, 1998, International journal of oncology.

Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patients

H. Yamana, Yuji Sato, S. Todo, 2002, British Journal of Cancer.

Identification of epidermal growth factor receptor-derived peptides immunogenic for HLA-A2+ cancer patients

Yuji Sato, S. Todo, S. Shichijo, 2004, British Journal of Cancer.